This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33331373
rdf:type
wikibase:Item
schema:description
vedecký článok مقالة علمية 1999년 논문 научни чланак videnskabelig artikel (udgivet 1999) научна статия vitenskapelig artikkel article scientifique (publié 1999) tieteellinen artikkeli artículu científicu espublizáu en 1999 บทความทางวิทยาศาสตร์ სამეცნიერო სტატია artigo científico (publicado na 1999) 1999年论文 artykuł naukowy artikull shkencor 1999年论文 1999年论文 1999 nî lūn-bûn wetenschappelijk artikel scientific article наукова стаття, опублікована у вересні 1999 artigo científico 1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված 1999年論文 1999年论文 articol științific bài báo khoa học מאמר מדעי scienca artikolo wissenschaftlicher Artikel vědecký článek teaduslik artikkel article scientific vetenskaplig artikel 1999年論文 1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած научни чланак tudományos cikk ১৯৯৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1999年論文 1999年论文 мақолаи илмӣ artigo científico (publicado na 1999) 1999年論文 научная статья article científic bilimsel makale articolo scientifico mokslinis straipsnis naučni članak vitskapeleg artikkel مقالهٔ علمی artikulong pang-agham мақолаи илмӣ 1999年论文 1999年の論文 artículo científico publicado en 1999 1999年論文 επιστημονικό άρθρο سائنسی مضمون
p:P577
wds:Q33331373-829BC744-E128-4A12-BFBD-FCBF18D2B253
wdt:P577
1999-09-01T00:00:00Z
p:P2860
wds:Q33331373-F9A34246-55AD-4E4A-9FDA-65862CB1697A wds:Q33331373-FFEE751F-0ABA-451B-A05C-96A42A61A085 wds:Q33331373-91F3169F-33F8-4CE1-B718-4DA23D6B9A03 wds:Q33331373-C0DE0ED6-C099-42CD-8BBA-53DA28ECB8A1 wds:Q33331373-308AFD28-F770-4D94-9686-9DF48D7CD241 wds:Q33331373-33192310-63A4-4CEC-B134-142FA570CE4A wds:Q33331373-027AC543-E89E-4C78-B614-FEEB9BBF2F85 wds:Q33331373-056ECB9E-2D67-41E4-8074-6B3F444DEFBE wds:Q33331373-81D73AC7-4128-4CF9-9301-B906B146FC99 wds:Q33331373-6814E645-7284-424F-92EA-70A9A1A94CD2
wdt:P2860
wd:Q73685231 wd:Q33499176 wd:Q34754672 wd:Q41999978 wd:Q54111829 wd:Q25938997 wd:Q54253599 wd:Q73177853 wd:Q77128596 wd:Q61868290
p:P2093
wds:Q33331373-F684ADEB-3A5E-4719-8060-132FCC80B65E wds:Q33331373-EC41257E-93B6-42BF-9589-21291D3F373E wds:Q33331373-8DFC2222-E792-4007-A9F4-3E27AA54DDC0 wds:Q33331373-8EC366EE-287F-4460-A3B9-1E04D02A05CA wds:Q33331373-8B4D4EE4-5467-4F8E-BE76-FC5589C62B42 wds:Q33331373-6B61679E-506D-4892-8F2A-29A7DF65E7A3 wds:Q33331373-709CEC99-5A64-494B-938B-6A2A7317E4FE wds:Q33331373-6643EAB7-F2D0-4A6B-AC5A-2023DD13B403 wds:Q33331373-2D648969-21FF-4C4C-B0CA-1EC6AEF8E3EB wds:Q33331373-3E010B99-7650-4332-AD45-AE1C4AD05E11 wds:Q33331373-44234C35-2FB9-4F9D-A5CF-70EB03731C81
wdt:P2093
Louvet C André T Gilles-Amar V Molitor JL Carola E de Gramont A Garcia ML Krulik M Maindrault-Goebel F Izrael V Lotz JP
rdfs:label
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
skos:prefLabel
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
schema:name
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer
p:P1476
wds:Q33331373-CA959E66-CE65-4B5A-A2F9-EBC0300F3F47
wdt:P1476
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
p:P304
wds:Q33331373-EBFEFC21-C3DE-42C1-8A93-CE953E295D46
wdt:P304
1338-1342
p:P31
wds:Q33331373-662C569F-810E-4F70-BA34-290D25183920
wdt:P31
wd:Q13442814
p:P921
wds:Q33331373-29D5A539-C3AB-4420-9965-FBD18BE02C05 wds:Q33331373-4F2539B5-DB94-452A-B836-1CDD43A02818 wds:Q33331373-7DAFF3A7-EDC1-48C3-B977-B1F68C730002 wds:Q33331373-B6F07670-D63E-434E-984E-4EBA6B4311F3 wds:Q33331373-D51A2D61-B6A4-4B3D-9699-563EAAB185CF
wdt:P921
wd:Q188874 wd:Q238512 wd:Q422327 wd:Q25493920 wd:Q108566365
p:P698
wds:Q33331373-60A870CF-B0E0-4314-B389-2BD472FE313A
wdtn:P698
n7:10658524
wdt:P698
10658524
p:P1433
wds:Q33331373-72763228-9495-4603-94C2-7FE87B2676BF
wdt:P1433
wd:Q332260
p:P433
wds:Q33331373-8D735E2D-C0E1-4C63-8D51-C635706D28EB
p:P478
wds:Q33331373-4A5F91EE-5B1A-498E-907B-5E61D715BDE9
wdt:P433
9
wdt:P478
35
p:P356
wds:Q33331373-BBC8A250-765C-45FB-AA0C-2E816BF6E4F6
wdtn:P356
n9:S0959-8049(99)00149-5
wdt:P356
10.1016/S0959-8049(99)00149-5